1.Jemal A, Center MM , Desantis C, Ward EM. Global patterns of cancer incidence and mortality rates an trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893-07.
- Abramyuk A, Appold S, ZöPhel K, Hietschold V, Baumann M, Abolmaali N. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy-A retrospective study. Lung Cancer.2012; 78 (2):148-52.
- Tournoy KG, Keller SM, Annema JT. Mediastinal staging of lung cancer: novel concepts. Lancet Oncol.2012; 13(5): e221-9.
- Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study. Lung Cancer. 2011; 71(3):333-7.
5.Tanoue LT. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Yearbook of Pulmonary Disease. 2009:162-4.
- Yip SSF, Aerts HJWL. Applications and limitations of radiomic. Physics in medicine and & biology. 2016; 61(13): R150-66.
7.Gillies RJ, Kinahan PE, Hricak H. Radiomic: images are more than pictures, they are data. Radiology. 2015;278 (2):563–77.
- Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 2012;30:1323-41.
- Fave X, Mackin D, Yang JZ,Zhang J,Frid D, Balter P, Followill D. Can radiomic features be reproducibly measured from CBCT images for patients with non-small cell lung cancer? Med Phys. 2015;42(12):6784-97.
10.Goldstraw P, Chansky K, Crowley J. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol.2016;11(1):39-51.
11.Pisters KM, Darling G. The iaslc lung cancer staging project: "the nodal zone". Journal of Thoracic Oncology, 2016;11(5): 639-50.
12.Huang Y, Liu Z, He L,Chen X, Pan D, Ma Z. Radiomic Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer. Radiology. 2016;281(3):947-57.
13.Liang W, He J, Shen Y, Shen J, He Q, Zhang J. Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi Institutional Registry. J Clin Oncol. 2017;35(11):1162-70.
14.Broderick SR, Patterson GA. Performance of integrated positron emission tomography/ computed tomography for mediastinal nodal staging in non-small cell lung carcinoma. Thorac Surg Clin.2013;23(2):193-8.
15.Liao CY, Chen JH, Liang JA, Yeh JJ, Kao CH.Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in nonsmall cell lung cancer: comparison of TB and non-TB endemic regions. Eur J Radiol. 2012;81(11):3518-23.
16.Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Víctor A, Marta Roqué I Figuls.PET/CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014;11(11) CD009519.
17.Shao T, Yu LJ, Li Y, Chen M,Chen, M, Petct M. Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer. Chinese Journal of Lung Cancer.2015;18(2):155-60
18.Bayanati H, E Thornhill R, Souza CA, Sethi-Virmani V, Gupta A,Maziak D. Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol. 2015;25(2):480-7.
- Andersen MB, Harders SW, Ganeshan B, Thygesen J, Madsen HHT, Rasmussen F.CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer. Acta Radiol.2016;57(6):669-76.
- Pham TD, Watanabe Y, Higuchi M, Suzuki H.Texture Analysis and Synthesis of Malignant and Benign Mediastinal Lymph Nodes in Patients with Lung Cancer on Computed Tomography. Sci Rep. 2017;7:43209.
- Dong Y, Feng Q, Yang W, Lu Z, Deng C, Zhang L. Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomic of T2-weighted fat-suppression and diffusion-weighted MRI. European Radiology. 2018;28(2):582-91.
- Huang YQ, Liang CH, He L, Tian J, Liang CS, ChenX. Development and validation of a radiomic nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol.2016; 34(18):2157-64.
- Shen C, Liu Z, Wang Z,Guo J, Zhang H, Wang Y.Building CT Radiomic Based Nomogram for Preoperative Esophageal Cancer Patients Lymph Node Metastasis Prediction. Translational Oncology. 2018; 11(3):815-24.
- Kim YK, Kyung Soo Lee, Byung-Tae Kim, Joon Young Choi, Hojoong Kim, O Jung Kwon.Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country : Diagnostic efficacy in 674 patients. Cancer, 2010, 109(6):1068-77.
- Picozzi NM, Pillai P, Phillips R, Gupta U, Coulden R, Beadsmoore C. Can the negative predictive value of CT-PET for mediastinal lymph node staging in non-small cell lung cancer be trusted? Lung Cancer.2008; 60(8):S6-S6.
26.Thomas P, Abhishek M,Rikiya Y,Jayasree C,Tome S, William RJ. Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging.2018;43(12):3271-8
27.Shen C, Liu Z, Wang Z, Guo J, Zhang H, Wang Y. Building CT Radiomic Based Nomogram for Preoperative Esophageal Cancer Patients Lymph Node Metastasis Prediction. Translational Oncology. 2018; 11(3):815-24.